Global Positive Patient Identification (PPID) Market Overview:
Positive patient identification (PPID) is an approach to maintaining a strategic distance from patient misidentification for the prevention of medical mistakes, which include errors in medication, transfusion, and testing, as well as wrong-person procedures and the discharge of newborn babies to the wrong family. Since the turn of the second millennium, healthcare authorizing bodies and the World Health Organization have emphasized the significance of tracking patients, medications, and information through PPID. Some of the players profiled in the study are Taylor Communications, Inc. (United States), Imprivata, Inc. (United States), ZIH Corp (United States), Identification Systems Group (United States), RightPatient Inc. (United States), Cerner Corporation (United States), Endur ID Incorporated (united States), GBS Corp (United States) and SATO Australia Pty Ltd. (Australia).
On the basis of geography, the market of Positive Patient Identification (PPID) has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by , the sub-segment i.e. will boost the Positive Patient Identification (PPID) market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Growth Drivers
- Technological Advancements in Medical Science
- Shift towards Cloud-Based Positive Patient Identification Solution
- Shift towards Biometric Positive Patient Identification Solutions
- Emphasis on Integration Capabilities
- High Initial Setup Cost
- Limitations in Processes result in Inaccurate Patient Identification
- Untapped Area of Developed Nation
- Generating and Implementing Unique Patient Identifiers (UPIs)
The companies are exploring the market by adopting expansions, investments, and new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations.
Target Audience:Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Government Regulatory and Research Organizations and End-Use Industries
Major Objectives Focused through this Study To define, describe, and forecast the Global Positive Patient Identification (PPID) market on the basis of product  , application , key regions and end user
To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
To provide market size for various segments of the Positive Patient Identification (PPID) market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
To strategically profile the key players and analyzing their market shares and core competencies in the Positive Patient Identification (PPID) industry
To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market
Available Customization: Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are PDC Healthcare (United States).
** Confirmation on availability of data would be informed prior purchase
While framing the research framework, major and emerging players operating in the Positive Patient Identification (PPID) market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.